Ajanta Pharma to Replace Aditya Birla Nuvo on Nifty Midcap 50

Ajanta Pharmaceuticals will be included in the NSE's Nifty Midcap 50 index, replacing Aditya Birla Nuvo from next month. According to the changes announced by India Index Services and Products Ltd (IISL), a subsidiary of NSE Strategic Investment Corporation, Ajanta Pharmaceuticals will be excluded from Nifty Midcap 50 index with effect from October 19, this year. In its place, Aditya Birla Nuvo, the holding company of Aditya Birla ...